Medication info
Megabon Tablet

Megabon Tablet

OTC medicationTablet경구Approval withdrawn
Ingredient · strength
Sodium Chondroitin Sulfate›600mg / 1 tabletFursultiamine›60mg / 1 tabletNicotinamide›60mg / 1 tabletAscorbic Acid›50mg / 1 tabletPyridoxine Hydrochloride›25mg / 1 tabletCyanocobalamin Powder 0.1%›20mg / 1 tabletInositol›20mg / 1 tabletCalcium Pantothenate›15mg / 1 tabletRiboflavin›12mg / 1 tabletGamma-Oryzanol›5mg / 1 tablet
Manufacturer / importer
하이플생명과학(주)
Appearance
Brown oblong film-coated tablet
Packaging
45 tablets/bottle, 90 tablets/box [45 tablets/bottle×2], 60 tablets/bottle, 120 tablets/box [60 tablets/bottle×2]
Approval status
Approval withdrawn

MFDS item code 202203147 · Notified 2022.08.01

This product's status changed to Approval withdrawn on 2026.02.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of physical fatigue and pain from neuralgia and myalgia
Who takes it
Adults
Adult dose
Aged 8 years and older and adults: 1 tablet once daily after meals

Ingredients

Manufacturer
하이플생명과학(주)

Efficacy & effects

Relief of physical fatigue and pain from neuralgia and myalgia

  • Physical fatigue
  • decline in stamina
  • neuralgia
  • myalgia
  • arthralgia
  • beriberi
  • eye fatigue
  • angular cheilitis
  • cheilitis
  • stomatitis
  • glossitis
  • eczema
View approved original text

This drug includes vitamins B1, B2, B6, and C, which help supplement during physical fatigue, pregnancy, lactation, and recovery after illness. It also aids in alleviating pain such as neuralgia, myalgia, and arthralgia. It is effective for inflammatory skin conditions like eye fatigue, angular cheilitis, cheilitis, stomatitis, and glossitis. It is also used to improve symptoms of skin eczema and dermatitis. Overall, this drug assists in the recovery of bodily health and alleviation of inflammation.

How to take

Adult dose

Aged 8 years and older and adults: 1 tablet once daily after meals

Precautions

This drug should not be taken by individuals allergic to or sensitive to soybean oil, soy, or peanuts. Additionally, those who have previously experienced allergic reactions to any of the components in this drug should avoid taking it. Infants under 3 months should also not use this drug. It is important not to take this drug concurrently with the medication Levodopa. Individuals receiving medical treatment or with specific health conditions should consult a specialist before taking this drug. This includes those with hyperoxaluria, gout, kidney stones, lipid metabolism disorders, pregnant or lactating women, premature infants, and children. If symptoms such as nausea, vomiting, diarrhea, inflammation of the mouth, decreased appetite, or abdominal distension occur during use, discontinue use immediately and consult a specialist. Prolonged high-dose use may lead to tolerance, and excessive intake of certain vitamins can cause neurological disorders or hematological adverse reactions, so caution is advised. High-dose use may cause side effects such as peptic ulcers, blood sugar regulation disorders, and liver damage. If symptoms do not improve after taking this drug for more than one month, consult a specialist. Always adhere to the prescribed dosage and administration. This drug may impact blood glucose measurement during urine tests, and may cause urine discoloration to yellow, which could affect test results. Patients with a risk of lipid overload should regularly monitor blood lipid levels, and if other lipid-regulating medications are being taken, the lipid intake should be adjusted. This drug should be stored out of reach of children, protected from direct sunlight, and kept in a cool, dry, sealed container. For quality maintenance, it is important not to transfer it to other containers.

Side effects and when to seek care immediately

Mild side effects

Nausea, vomiting, loose stools, diarrhea, stomatitis, decreased appetite, abdominal distension, sensory neuropathy or neurological symptoms, hematological adverse reactions, exacerbation of peptic ulcers, impaired glucose tolerance, hyperuricemia, liver damage

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air or moisture ingress, preferably at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy for a longer time.

Appearance and packaging

Appearance

Brown oblong film-coated tablet

Package unit

45 tablets/bottle, 90 tablets/box [45 tablets/bottle×2], 60 tablets/bottle, 120 tablets/box [60 tablets/bottle×2]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.